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Abstract
Introduction
• Pre-participation physical examinations are routinely 
conducted in the United States in an effort to protect 
young athletes.  
• There are numerous estimates regarding the incidence of 
sudden cardiac death (SCD) in athletes, ranging from one 
in 40,000 to one in 80,000, and though SCD is a rare 
occurrence the multifactorial effects on the surrounding 
community cannot be denied.  
• The majority of recommendations surrounding these 
physicals support gathering a personal and family history 




Applicability to Clinical 
Practice
Discussion 
• None of the contemporary criteria included children less 
than 14 years of age in their studies, nor were they 
intended for use by primary care clinicians alone.
• Leger et al. (2016) point out that there is a significant
overlap in normal pediatric EKG findings with adult 
pathological EKG findings, and that no current data exists 
on the physiologic cardiac modifications related to 
exercise in children thus making EKG less effective as a 
screening tool in children than adults.
• Inclusion of screening electrocardiograms (EKGs) during 
pre-participation physical examination has been a topic of 
debate for some time.  There is unquestioned usefulness 
in the ability of a well-trained health care provider in using 
EKG to identify cardiac abnormalities.  
• Further, there have been several contemporary EKG 
criteria published that increase specificity and sensitivity of 
detection of disease.  However, these criteria do not 
account for athletes less than 14 years of age, and that 
demographic represents a large portion of patients 
seeking pre-participation screenings in the United States.  
• The lack of research into pediatric cardiac remodeling 
secondary to activity, coupled with the significant overlap 
in normal pediatric EKG findings with adult pathological 
EKG findings create a difficult position for any health care 
provider.  
• A literature review was performed to determine if 
screening EKGs are effective both medically and 
economically in athletes less than 14 years of age.  
• Based on the review, the limitations of contemporary EKG 
criteria, the inability to prove cost effectiveness in the US 
healthcare model, and the lack of research into activity 
modulated pediatric cardiac remodeling should reinforce 
that the ACC/AHA checklist is an appropriate foundation 
for conducting pre-participation physical examination. 
• Concerns for the provider when interpreting an athlete’s 
EKG include both missing a dangerous cardiac condition 
and generating false-positive interpretations that cause 
needless further investigations, increased economic cost, 
and potentially unnecessary activity restriction for the 
athlete (Drezner et al., 2013).
• The ACC/AHA check sheet provides an appropriate 
foundation for screening.  If suspect findings present 
themselves, specialist referral prior to participation is 
appropriate.
• Provider-directed risk stratification of proposed activity 
levels is also appropriate.
Statement of the Problem
In patients requiring pre-participation physical examination, 
would EKG be an effective screening tool, both medically 
and economically, to identify conditions that may cause SCD 
in athletes younger than 14 years old?
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• Many of the underlying pathologies that lead to SCD 
produce subtle findings on exam and are difficult for even 
an experienced Primary Care Provider to detect 
(Finocchiaro et al., 2016).
• Between 2013 and 2023, 170 million high school and 
college athletes will require pre-participation physical 
examination.  No estimate is available for primary school 
children.
Contemporary EKG interpretation criteria
• The European Society of Cardiology (ESC) released 
recommendations intended to improve specificity 
secondary to increasing number of unacceptably high 
levels of false positive EKGs. 
• The ESC recommendations were followed by the Seattle 
and refined criteria, which further improved sensitivity and 
reduced the abnormal rate of EKG to 9.6% and 6.6% 
(p<0.001) respectively.
EKG abnormality ESC recommendations Seattle Criteria Refined criteria
Left atrial enlargement Negative portion of the P 
wave in lead V1 > 0.1 mV 
in depth and > 40 ms in 
duration
Prolonged P wave 
duration of > 120 ms in 
lead I or II with negative 
portion of the P wave > 1 
mm in depth and > 40 




P wave amplitude > 2.5 
mm in lead II, III, or aVF
As ESC As ESC
Left QRS axis 
deviation
-30 to -90 degrees As ESC As ESC
Right QRS axis 
deviation
> 115 degrees As ESC AS ESC
Right ventricular 
hypertrophy
Sum of R wave in V1 and 
S wave in V5 or V6 > 10.5 
mm
Sum of R wave in V1 
and S wave in V5 > 10.5 
and right axis deviation > 
120 degrees
As ESC
Complete LBBB QRS > 120 ms, 
predominantly negative 
QRS complex in lead V1 
(QS or rS), and upright 
monophasic R wave in 
leads I and V6
As ESC As ESC
Complete RBBB RSR’ pattern in anterior 
precordial leads with QRS 
duration > 120 ms
Not relevant As ESC
Intraventricular
conduction delay
Any QRS duration > 120 
ms including RBBB and 
LBBB
Any QRS duration > 140 
ms or complete LBBB
As ESC
Pathological Q wave > 4 mm deep in any lead 
except III, aVR
>3 mm deep or > 40 ms 
duration in > 2 leads 
except III and aVR
> 40 ms duration or 
>25% of the height of 
the ensuing R wave 
Significant T wave 
inversion
> 2 mm in > 2 adjacent 
leads (deep) or “minor” in 
> 2 leads
> 1 mm in depth in > 2 
leads V2-V6, II and aVF, 
or I and aVL (excludes 




> 0.5 mm deep in > 2 
leads
As ESC As ESC
Ventricular pre-
excitation
PR interval < 120 ms with 
or without delta wave
PR interval < 120 ms 
with delta wave
As Seattle criteria
From “Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and 
White Athletes”, by N. Sheikh, M. Papadakis, S. Ghani, A. Zaidi S. Gati, P.E. Adami, F. Carre  F. Schnell, M. Wilson, 
P. Avila, W. McKenna, S. Sharma, 2014, Circulation, 129(16), p. 1640.  Copyright 2014 American Heart Association 
Inc.  Reprinted with permission.
Economic Impact
• Corrado et al., (2006) reported a marked decline in SCD 
among athletes after the implementation of Italian law 
mandating EKG screening.
• Halkin et al. (2012) recognized that the Corrado study 
failed to address economic impact. They executed a cost-
progression model that estimated the cost of screening 
EKG would reach $69 billion in the US by 2023.
• European studies provide more favorable economic 
outcomes, reducing cost to approximately $87 dollars per 
athlete (Dhutia et al., 2016), but the data lacks portability 
to the US secondary to dissimilar health care models and 
degree of subsidization.
Current recommendations
• The American Heart Association and the American 
College of Cardiology recommend a 14 item checklist 
when executing a pre-participation screening: 
14 Element Cardiovascular Screening Checklist for Congenital and Genetic Heart Diseases
Personal History
1. Chest pain/discomfort/tightness/pressure related to exertion
2. Unexplained syncope/near syncope*
3. Excessive exertional and unexplained dyspnea/fatigue or palpitations associated with 
exercise
4. Prior recognition of a heart murmur
5. Elevated systemic blood pressure
6. Prior restriction from participation in sports
7. Prior testing for the heart, ordered by a physician
Family History
8. Premature death (sudden and unexplained, or otherwise) before age 50 attributable to heart 
disease in > 1 relative
9. Disability from heart disease in close relative < 50 years of age
10. Hypertrophic of dilated cardiomyopathy, long QT syndrome, or other ion challenopatihes, 
Marfan syndrome, or clinically significant arrhythmias, specific knowledge of certain cardiac 
conditions in family members
Physical Examination
11. Heart murmur**
12. Femoral pulses to exclude aortic coarctation
13. Physical stigmata of Marfan syndrome
14. Brachial artery pressure (sitting position, preferably taken in both arms
*Judged not to be of a neurocardiogenic (vasovagal) origin; of particular concern when occurring 
during or after physical exertion.
**Refers to heart murmurs judged to be organic and unlikely to be innocent; auscultation should be 
performed with the patient in both the supine and standing positions (or with Valsalva maneuver), 
specifically to identify murmurs of dynamic left ventricular outflow tract obstruction.
ACC/AHA Release Recommendations for Congenital and Genetic Heart Disease Screenings in 
Youth (2014).  Retrieved from http://www.acc.org/latest-in-cardiology/articles/2014/09/15/14/24/acc-
aha-release-recommendations-for-congenital-and-genetic-heart-disease-screenings-in-youth.
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